Posted by Michael Wonder on 26 Jul 2021
Evren Technologies receives FDA breakthrough device designation for the Phoenix
21 July 2021 - Evren Technologies announced today that its non-invasive Phoenix earbud device received Breakthrough Device Designation from the U.S. FDA for the treatment of post-traumatic stress disorder.
Evren’s Phoenix device provides personalised medicine that addresses the underlying autonomic imbalance of post-traumatic stress disorder by delivering therapeutic levels of transcutaneous auricular vagal nerve stimulation in a proprietary, closed-loop, discreet, and wireless earbud design.
